FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer

NCT02317302 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

48

Enrollment

OTHER

Sponsor class

Stopped Insufficient funding

Conditions

Cervical Cancer
Uterine Cervical Cancer
Uterine Cervical Neoplasms

Interventions

DEVICE: FDG-PET/MR
DEVICE: FDG-PET/CT

Sponsor

Washington University School of Medicine